Newron Pharmaceuticals SpA Eulerpool Nieuws

Newron Pharmaceuticals SpA Eulerpool News

Newron Pharmaceuticals SpA Aandeel Nieuws

Newron Pharmaceuticals SpA wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele Newron Pharmaceuticals SpA nieuwsberichten verzamelen we hier.

• 5 juni ·

  Yahoo
  Newron Pharmaceuticals Will Host Its 2024 Investor Day on June 25 in New York City
• 13 mei ·

  Yahoo
  Newron Reports Compelling Additional Data Documenting the Efficacy of Evenamide in Pivotal Study 008A in Poorly Responding Schizophrenia Patients
• 30 april ·

  Yahoo
  Newron Announces Positive Top-line Results From Potentially Pivotal Phase II/III Study 008A With Evenamide in Schizophrenia Patients
• 8 april ·

  Yahoo
  Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)
• 19 maart ·

  Yahoo
  Newron Presents 2023 Financial Results and Provides 2024 Outlook
• 15 maart ·

  Yahoo
  Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreement
• 4 januari ·

  Yahoo
  Newron Reports Exceptional One-year Results of Study 014/15 With Evenamide in Treatment-resistant Schizophrenia (TRS)
• 29 december ·

  Yahoo
  Newron Completes Enrollment of Schizophrenia Patients in Potentially Pivotal Study 008A With Evenamide
• 9 oktober ·

  Yahoo
  Newron TRS Study 6 Months’ Results: Evenamide Substantially Improves Patients to an Extent That They No Longer Meet Protocol Entry Criteria
• 4 oktober ·

  Yahoo
  Newron to Present Three Posters on Its Clinical Program Evaluating Evenamide in the Treatment of Schizophrenia at the 36th European College of Neuropsychopharmacology Congress